272 related articles for article (PubMed ID: 20673970)
1. The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.
Dewdney SB; Rimel BJ; Reinhart AJ; Kizer NT; Brooks RA; Massad LS; Zighelboim I
Gynecol Oncol; 2010 Oct; 119(1):18-21. PubMed ID: 20673970
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy or primary debulking surgery in FIGO IIIC and IV patients; results from a survey study in the Netherlands.
Timmermans M; Sonke GS; van Driel WJ; Lalisang RI; Ottevanger PB; de Kroon CD; Van de Vijver KK; van der Aa MA; Kruitwagen RF
Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():98-102. PubMed ID: 29525755
[TBL] [Abstract][Full Text] [Related]
3. What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?
Eisenkop SM; Spirtos NM
Gynecol Oncol; 2001 Sep; 82(3):489-97. PubMed ID: 11520145
[TBL] [Abstract][Full Text] [Related]
4. Role of neoadjuvant chemotherapy in the management of stage IIIC-IV ovarian cancer: survey results from the members of the European Society of Gynecological Oncology.
Cornelis S; Van Calster B; Amant F; Leunen K; van der Zee AG; Vergote I
Int J Gynecol Cancer; 2012 Mar; 22(3):407-16. PubMed ID: 22367320
[TBL] [Abstract][Full Text] [Related]
5. Practice patterns of SGO members for stage IIIA endometrial cancer.
Lee CM; Slomovitz BM; Greer M; Sharma S; Gregurich MA; Burke T; Lu KH; Ramondetta LM
Gynecol Oncol; 2005 Jul; 98(1):77-83. PubMed ID: 15907988
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?
Vergote I; Amant F; Leunen K
Gynecol Oncol; 2010 Oct; 119(1):1-2. PubMed ID: 20833283
[No Abstract] [Full Text] [Related]
7. A survey of blood transfusion practices of gynecologic oncologists.
Price FV; Kelley JL; Edwards RP; Hasley PB; Amin RM
Gynecol Oncol; 1995 Oct; 59(1):45-50. PubMed ID: 7557614
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy as ovarian cancer treatment: ever more used with major regional differences.
Fagö-Olsen CL; Ottesen B; Kehlet H; Markauskas A; Mosgaard BJ; Ottosen C; Søgaard CH; Søgaard-Andersen E; Høgdall C
Dan Med J; 2012 Aug; 59(8):A4477. PubMed ID: 22849978
[TBL] [Abstract][Full Text] [Related]
9. Influence of the gynecologic oncologist on the survival of ovarian cancer patients.
Chan JK; Kapp DS; Shin JY; Husain A; Teng NN; Berek JS; Osann K; Leiserowitz GS; Cress RD; O'Malley C
Obstet Gynecol; 2007 Jun; 109(6):1342-50. PubMed ID: 17540806
[TBL] [Abstract][Full Text] [Related]
10. The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005.
Naumann RW; Coleman RL
Gynecol Oncol; 2007 Apr; 105(1):7-12. PubMed ID: 17187847
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant chemotherapy for advanced epithelial ovarian cancer].
Hatae M; Onishi Y; Nakamura T; Yamamoto H; Kusumoto M; Matsui T; Mihara K; Taniguchi H
Gan To Kagaku Ryoho; 2001 Nov; 28(12):1833-7. PubMed ID: 11729475
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
[TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant chemotherapy and ovarian cancer].
Ray-Coquard I; Saba C; Bachelot T; Méeus P; Mignotte H; Blondet R; Treilleux I; Peix M; Guastalla JP
Bull Cancer; 2006 Jul; 93(7):669-76. PubMed ID: 16873075
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
[TBL] [Abstract][Full Text] [Related]
15. Defining practice patterns in gynecologic oncology to prevent pulmonary embolism and deep venous thrombosis.
Martino MA; Williamson E; Rajaram L; Lancaster JM; Hoffman MS; Maxwell GL; Clarke-Pearson DL
Gynecol Oncol; 2007 Sep; 106(3):439-45. PubMed ID: 17599396
[TBL] [Abstract][Full Text] [Related]
16. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
Naumann RW; Sukumvanich P; Edwards RP
Gynecol Oncol; 2009 Jul; 114(1):37-41. PubMed ID: 19410281
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training.
Frumovitz M; Ramirez PT; Greer M; Gregurich MA; Wolf J; Bodurka DC; Levenback C
Gynecol Oncol; 2004 Sep; 94(3):746-53. PubMed ID: 15350368
[TBL] [Abstract][Full Text] [Related]
18. The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer.
Weinberg LE; Rodriguez G; Hurteau JA
J Surg Oncol; 2010 Mar; 101(4):334-43. PubMed ID: 20187069
[TBL] [Abstract][Full Text] [Related]
19. Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease.
Ferron JG; Uzan C; Rey A; Gouy S; Pautier P; Lhommé C; Duvillard P; Morice P
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):101-5. PubMed ID: 19740592
[TBL] [Abstract][Full Text] [Related]
20. The benefits of a gynecologic oncologist: a pattern of care study for endometrial cancer treatment.
Roland PY; Kelly FJ; Kulwicki CY; Blitzer P; Curcio M; Orr JW
Gynecol Oncol; 2004 Apr; 93(1):125-30. PubMed ID: 15047225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
